Intein mediated high throughput screening for bispecific antibodies
Tim Hofmann1,2, Johannes Schmidt3, Elke Ciesielski2
1Institute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany.
Mabs
|March 11, 2020
Summary
This study introduces a new method for screening bispecific antibodies using split intein technology. This approach enables automated, high-throughput evaluation of diverse antibody combinations, accelerating therapeutic development.
Area of Science:
- Biotechnology
- Immunology
- Pharmaceutical Sciences
Background:
- Bispecific antibodies offer advanced therapeutic capabilities beyond monospecific antibodies.
- Current screening methods for bispecific antibodies are limited in evaluating the vast number of potential combinations, leading to extended development times.
- High-throughput screening (HTS) for small molecules and conventional antibodies is well-established, but lacks efficiency for bispecific antibody discovery.
Purpose of the Study:
- To develop a novel combinatorial screening approach for bispecific IgG-like antibodies.
- To overcome the limitations of current screening methodologies in terms of scale and combinatorial space coverage.
- To enable rapid, automated, and efficient high-throughput screening of bispecific antibody candidates.
Main Methods:
- Utilized a protein trans-splicing reaction mediated by the split intein Npu DnaE.
- Reconstituted antibody fragments within the hinge region in vitro.
- Developed a fully automated, one-pot antibody reconstitution process.
Main Results:
- The novel method allows for rapid antibody reconstitution and demonstrates biological activity in various assays.
- The approach significantly expands the screening space for bispecific antibody combinations.
- The technology is suitable for automated functional and combinatorial high-throughput screening.
Conclusions:
- The presented protein trans-splicing method offers a powerful tool for bispecific antibody discovery.
- This innovation addresses the limitations in current bispecific antibody screening, facilitating faster development of novel therapeutics.
- The automated, high-throughput screening approach accelerates the evaluation of diverse bispecific antibody architectures.
Keywords:
High throughput Screeningantibodyantibody discoveryautomationbispecific antibodysplit inteins

